IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Log in (now much improved!) to follow this author

Fabio Pammolli

This is information that was supplied by Fabio Pammolli in registering through RePEc. If you are Fabio Pammolli, you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name:Fabio
Middle Name:
Last Name:Pammolli
Suffix:
RePEc Short-ID:ppa382
http://www.dig.polimi.it/index.php?id=714&tx_wfqbe_pi1%5Bid%5D=750
DIG, Politecnico di Milano, Via Lambruschini 4B 20156 Milano, Italia
Milano, Italy
http://www.dig.polimi.it/

:

Piazza L. da Vinci 32, 20133 Milano
RePEc:edi:dipomit (more details at EDIRC)
Siena, Italy
http://www.cermlab.it/

: +39 3476005404

Via Fiorentina, 1, 53100 Siena
RePEc:edi:cermmit (more details at EDIRC)
in new window
  1. Bendetta Frassi & Christian Hagist & Fabio Pammolli, 2017. "Who is this, who enters there? - Migration in Italy and its effect on fiscal sustainability and pensions," WHU Working Paper Series - Economics Group 17-01, WHU - Otto Beisheim School of Management.
  2. Benedetta Frassi & Fabio Pammolli & Luca Regis, 2017. "The potential costs of Longevity Risk on Public Pensions. Evidence from Italian data," Working Papers 01/2017, IMT Institute for Advanced Studies Lucca, revised Jan 2017.
  3. Fabio Pammolli & Armando Rungi, 2016. "Access to Medicines and European Market Integration," Working Papers 01/2016, IMT Institute for Advanced Studies Lucca, revised Jan 2016.
  4. Andrea Flori & Simone Giansante & Fabio Pammolli, 2016. "Peer-Group Detection of Banks and Resilience to Distress," Working Papers 06/2016, IMT Institute for Advanced Studies Lucca, revised Dec 2016.
  5. Andrea Flori & Giuseppe Pappalardo & Michelangelo Puliga & Alessandro Chessa & Fabio Pammolli, 2016. "The Accounting Network: how financial institutions react to systemic crisis," Papers 1605.01976, arXiv.org.
  6. Michele Bonollo & Irene Crimaldi & Andrea Flori & Laura Gianfagna & Fabio Pammolli, 2015. "Assessing financial distress dependencies in OTC markets: a new approach by Trade Repositories data," Working Papers 10/2015, IMT Institute for Advanced Studies Lucca, revised Oct 2015.
  7. Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Guido Borà, 2015. "La spesa sanitaria delle Regioni in Italia - Saniregio 2015," Working Papers CERM 01-2015, Competitività, Regole, Mercati (CERM), revised 04 Jan 2016.
  8. Michele Bonollo & Irene Crimaldi & Andrea Flori & Fabio Pammolli & Massimo Riccaboni, 2015. "Systemic risk and banking regulation: some facts on the new regulatory framework," Working Papers 1/2015, IMT Institute for Advanced Studies Lucca, revised Jan 2015.
  9. Michele Bonollo & Irene Crimaldi & Andrea Flori & Fabio Pammolli & Massimo Riccaboni, 2014. "Systemic importance of financial institutions: regulations, research, open issues, proposals," Working Papers 2/2014, IMT Institute for Advanced Studies Lucca, revised Mar 2014.
  10. Andrea Morescalchi & Fabio Pammolli & Orion Penner & Alexander M. Petersen & Massimo Riccaboni, 2014. "The evolution of networks of innovators within and across borders: Evidence from patent data," Working Papers 1/2014, IMT Institute for Advanced Studies Lucca, revised Jan 2014.
  11. Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Guido Borà, 2014. "La spesa sanitaria delle Regioni in Italia - Saniregio 3," Working Papers CERM 02-2014, Competitività, Regole, Mercati (CERM).
  12. Laura Magazzini & Fabio Pammolli & Valentina Tortolini, 2014. "Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell'Italia nel contesto europeo," Working Papers CERM 01-2014, Competitività, Regole, Mercati (CERM).
  13. Michele Bonollo & Irene Crimaldi & Andrea Flori & Fabio Pammolli & Massimo Riccaboni, 2014. "Systemic importance of financial institutions: from a global to a local perspective? A network theory approach," Working Papers 9/2014, IMT Institute for Advanced Studies Lucca, revised Sep 2014.
  14. Magazzini Laura & Fabio Pammolli, 2013. "R&D, Within and Between Patent Competition in the Pharmaceutical Industry," Working Papers 3/2013, IMT Institute for Advanced Studies Lucca, revised Jul 2013.
  15. Fabio Pammolli, 2013. "Demography, Sustainability, and Growth Notes on the future of the European "Social Market" Economy," Working Papers CERM 01-2013, Competitività, Regole, Mercati (CERM).
  16. Andrea Morescalchi & Fabio Pammolli & Orion Penner & Petersen Alexander M. & Massimo Riccaboni, 2013. "Networks of innovators within and across borders. Evidence from patent data," Working Papers 4/2013, IMT Institute for Advanced Studies Lucca, revised Aug 2013.
  17. Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2012. "I Farmaci Oncologici in Italia: innovazione e sostenibilità economica," Working Papers CERM 02-2012, Competitività, Regole, Mercati (CERM).
  18. Pammolli, Fabio & Salerno, Nicola, 2012. "La Sostenibilità dei Sistemi Sanitari Regionali
    [The Financial Sustainability of Italian Regional Health Care Systems]
    ," MPRA Paper 36927, University Library of Munich, Germany.
  19. Jing-Yuan Chio & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2012. "The Value of Failures in Pharmaceutical R&D," Working Papers 1/2012, IMT Institute for Advanced Studies Lucca, revised Jan 2012.
  20. Salerno, Nicola Carmine & Pammolli, Fabio, 2012. "La Riforma del Welfare, il Paygo, i nuovi Ammortizzatori per il Mercato del Lavoro
    [Reform of Welfare System, Scale of functioning of PayGo, and development of modern Unemployment Benefits]
    ," MPRA Paper 38396, University Library of Munich, Germany, revised 15 Apr 2012.
  21. Pammolli, Fabio & Salerno, Nicola, 2011. "Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM
    [Regional differences in the governance of health care expenditure
    ," MPRA Paper 36934, University Library of Munich, Germany.
  22. Fabio Pammolli & Nicola Carmine Salerno, 2011. "Federalismo e riparto del Fsn-2011: Much Ado About Nothing?," Working Papers CERM 01-2011, Competitività, Regole, Mercati (CERM).
  23. Massimo, Riccaboni & Jakub, Growiec & Fabio, Pammolli, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," MPRA Paper 30046, University Library of Munich, Germany.
  24. Pammolli, Fabio & Salerno, Nicola, 2011. "The Multipillar System for Health Care Financing: Thirteen Good Reasons for Open Capitalisation Funds, Covering both Pension and Health Care Provisions," MPRA Paper 36928, University Library of Munich, Germany.
  25. Fabio Pammolli & Nicola Carmine Salerno, 2011. "Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011," Working Papers CERM 02-2011, Competitività, Regole, Mercati (CERM).
  26. Fabio Pammolli & Nicola Carmine Salerno, 2011. "Le proiezioni della spesa sanitaria Ssn - SaniMod 2011-2030," Working Papers CERM 03-2011, Competitività, Regole, Mercati (CERM).
  27. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2010. "The productivity crisis in pharmaceutical R&D," Working Papers 06/2010, University of Verona, Department of Economics.
  28. Fabio Pammolli & Nicola Carmine Salerno, 2010. "La regolamentazione delle farmacie in Italia," Working Papers CERM 04-2010, Competitività, Regole, Mercati (CERM).
  29. Fabio Pammolli & Nicola Carmine Salerno, 2010. "I numeri del federalismo: una simulazione per la sanità," Working Papers CERM 01-2010, Competitività, Regole, Mercati (CERM).
  30. Fabio Pammolli & Nicola Carmine Salerno, 2010. "L'integrazione pubblico-privato in sanità e assistenza alla persona," Working Papers CERM 05-2010, Competitività, Regole, Mercati (CERM).
  31. Fabio Pammolli & Nicola Carmine Salerno, 2010. "I numeri del Federalismo in Sanità - Benchmarking e Standard su profili di spesa sanitaria per età," Working Papers CERM 03-2010, Competitività, Regole, Mercati (CERM).
  32. Fabio Pammolli & Nicola Carmine Salerno, 2010. "I numeri del Federalismo in Sanità - Benchmark e Standard per la Sanità Italiana, in attesa della decretazione attuativa della Legge n. 42-2009," Working Papers CERM 02-2010, Competitività, Regole, Mercati (CERM).
  33. Fabio Pammolli & Nicola Carmine Salerno, 2010. "I trend della spesa sanitaria e le ragioni del finanziamento multipillar con componente ad accumulazione reale," Working Papers CERM 06-2010, Competitività, Regole, Mercati (CERM).
  34. Fabio Pammolli & Massimo Riccaboni, 2009. "Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali," Working Papers CERM 04-2009, Competitività, Regole, Mercati (CERM).
  35. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent Disclosure and R&D Competition in Pharmaceuticals," ROCK Working Papers 053, Department of Computer and Management Sciences, University of Trento, Italy, revised 11 Jun 2009.
  36. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2009. "Nuove politiche per l'innovazione nel settore delle scienze della vita," Working Papers CERM 03-2009, Competitività, Regole, Mercati (CERM).
  37. Davide Integlia & Fabio Pammolli, 2009. "I farmaci ospedalieri tra Europa, Stato, Regioni e Cittadini," Working Papers CERM 01-2009, Competitività, Regole, Mercati (CERM).
  38. Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2009. "La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio," Working Papers CERM 02-2009, Competitività, Regole, Mercati (CERM).
  39. Massimo Riccaboni & Fabio Pammolli & Sergey V. Buldyrev & Linda Ponta & H. Eugene Stanley, 2009. "The Size Variance Relationship of Business Firm Growth Rates," ROCK Working Papers 052, Department of Computer and Management Sciences, University of Trento, Italy, revised 11 Jun 2009.
  40. Pammolli, Fabio & Riccaboni, Massimo & Magazzini, Laura, 2008. "The Sustainability of European Health Care Systems: Beyond Income and Ageing," MPRA Paper 16026, University Library of Munich, Germany.
  41. Roberto Cicciomessere & Fabio Pammolli & Nicola Carmine Salerno, 2008. "Mezzogiorno d'Italia - Primo Baedeker dello sviluppo territoriale e regionale," Working Papers CERM 04-2008, Competitività, Regole, Mercati (CERM).
  42. Fabio Pammolli & Nicola Carmine Salerno, 2008. "Occupazione, produttività e demografia: le sfide per la crescita del Mezzogiorno - Riforme strutturali per dare basi al federalismo," Working Papers CERM 02-2008, Competitività, Regole, Mercati (CERM).
  43. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2008. "Patent Value and R&D Competition," Working Papers 51/2008, University of Verona, Department of Economics.
  44. Maksim Kitsak & Massimo Riccaboni & Shlomo Havlin & Fabio Pammolli & H. Eugene Stanley, 2008. "Structure of Business Firm Networks and Scale-Free Models," ROCK Working Papers 051, Department of Computer and Management Sciences, University of Trento, Italy, revised 16 Jan 2009.
  45. Fabio Pammolli & Nicola Carmine Salerno, 2008. "Inflazione, bassa crescita, Euro forte: tra problemi europei ed economia globale," Working Papers CERM 01-2008, Competitività, Regole, Mercati (CERM).
  46. Fabio Pammolli & Nicola Carmine Salerno, 2008. "La sanità in Italia - tra federalismo, regolazione dei mercati e sostenibilità delle finanze pubbliche," Working Papers CERM 03-2008, Competitività, Regole, Mercati (CERM).
  47. Pammolli, Fabio & Cambini, Carlo & Giannaccari, Andrea, 2007. "Introduzione. Liberalizzazioni e concorrenza in Italia
    [Introduction. Liberalisation and competition in Italy]
    ," MPRA Paper 16125, University Library of Munich, Germany.
  48. Arora, Ashish & Gambardella, Alfonso & Magazzini, Laura & Pammolli, Fabio, 2007. "A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development," MPRA Paper 16042, University Library of Munich, Germany.
  49. Fabio Pammolli & Nicola Carmine Salerno, 2007. "La distribuzione al dettaglio dei farmaci - tra regolazione efficiente e mercato," Working Papers CERM 01-2007, Competitività, Regole, Mercati (CERM).
  50. Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale," Working Papers CERM 03-2007, Competitività, Regole, Mercati (CERM).
  51. Kitsak, Maksim & Havlin, Shlomo & Paul, Gerald & Riccaboni, Massimo & Pammolli, Fabio & Stanley, H. Eugene, 2007. "Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks," MPRA Paper 15907, University Library of Munich, Germany.
  52. Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico," Working Papers CERM 04-2007, Competitività, Regole, Mercati (CERM).
  53. Chiara Bonassi & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica," Working Papers CERM 02-2007, Competitività, Regole, Mercati (CERM).
  54. Laura Magazzini & Fabio Pammolli & Nicola Carmine Salerno, 2006. "La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica," Working Papers CERM 03-2006, Competitività, Regole, Mercati (CERM).
  55. Buldyrev, Sergey V. & Pammolli, Fabio & Riccaboni, Massimo & Yamasaki, Kazuko & Fu, Dongfeng & Matia, Kaushik & Stanley, H. Eugene, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment," MPRA Paper 15980, University Library of Munich, Germany.
  56. Pammolli, Fabio & Fu, Dongfeng & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2006. "A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence," MPRA Paper 15983, University Library of Munich, Germany.
  57. Fabio Pammolli & Nicola Carmine Salerno, 2006. "Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine," Working Papers CERM 02-2006, Competitività, Regole, Mercati (CERM).
  58. Fabio Pammolli & Nicola Carmine Salerno, 2006. "La nuova fiscalità della previdenza complementare per il lavoratore, l'impresa e l'Erario - Una quantificazione per il lavoratore dipendente neoassunto del settore privato con turnover decennale di da," Working Papers CERM 01-2006, Competitività, Regole, Mercati (CERM).
  59. Fabio Pammolli & Nicola Carmine Salerno, 2005. "Opting-out previdenziale, smobilizzo del TFR e basi strutturali del pilastro privato," Working Papers CERM 04-2005, Competitività, Regole, Mercati (CERM).
  60. Fu, Dongfeng & Pammolli, Fabio & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene, 2005. "The Growth of Business Firms: Theoretical Framework and Empirical Evidence," MPRA Paper 15905, University Library of Munich, Germany.
  61. Kaushik Matia & Dongfeng Fu & Sergey V. Buldyrev & Fabio Pammolli & Massimo Riccaboni & H. Eugene Stanley, 2005. "Statistical Properties of Business Firms Structure and Growth," Papers physics/0502081, arXiv.org.
  62. Fabio Pammolli & Nicola Carmine Salerno, 2005. "Alcuni vantaggi "minori" del contributivo: Ricongiunzione e Totalizzazione," Working Papers CERM 02-2005, Competitività, Regole, Mercati (CERM).
  63. Pammolli, Fabio & Riccaboni, Massimo & Oglialoro, Claudia & Magazzini, Laura & Baio, Gianluca & Salerno, Nicola, 2005. "Medical Devices Competitiveness and Impact on Public Health Expenditure," MPRA Paper 16021, University Library of Munich, Germany.
  64. Fabio Pammolli & Nicola Carmine Salerno, 2005. "Il disegno delle nuove agevolazioni fiscali alla previdenza complementare - una quantificazione per un lavoratore dipendente neoassunto del settore privato," Working Papers CERM 03-2005, Competitività, Regole, Mercati (CERM).
  65. Laura Magazzini & Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2005. "Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN," Working Papers CERM 01-2005, Competitività, Regole, Mercati (CERM).
  66. Yamasaki, Kazuko & Matia, Kaushik & Buldyrev, Sergey V. & Fu, Dongfeng & Pammolli, Fabio & Riccaboni, Massimo & Stanley, H. Eugene, 2004. "Preferential attachment and growth dynamics in complex systems," MPRA Paper 15908, University Library of Munich, Germany, revised 06 Feb 2006.
  67. Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo, 2004. "Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure," MPRA Paper 15968, University Library of Munich, Germany.
  68. Marianna Madia & Fabio Pammolli & Nicola Carmine Salerno, 2004. "In attesa del federalismo compiuto: LEA, spesa sanitaria e risorse finanziarie a livello regionale," Working Papers CERM 04-2004, Competitività, Regole, Mercati (CERM).
  69. Fabio Pammolli & Nicola Carmine Salerno, 2004. "Gli andamenti della spesa sanitaria: l'Italia in una sintetica comparazione internazionale," Working Papers CERM 01-2004, Competitività, Regole, Mercati (CERM).
  70. Fabio Pammolli & Nicola Carmine Salerno, 2004. "Le proiezioni di lungo periodo della spesa sociale nell'UE: l'impatto demografico e il possibile impatto della tecnologia sulla spesa sanitaria," Working Papers CERM 02-2004, Competitività, Regole, Mercati (CERM).
  71. Pammolli, Fabio & Riccaboni, Massimo, 2004. "Market Structure and Drug Innovation," MPRA Paper 16212, University Library of Munich, Germany.
  72. Fabio Pammolli & Pietro Rizza & Nicola Carmine Salerno, 2004. "Regole pensionistiche e incentivi al prolungamento della vita lavorativa: analisi del caso italiano," Working Papers CERM 06-2004, Competitività, Regole, Mercati (CERM).
  73. Fabio Pammolli & Nicola Carmine Salerno, 2004. "Regole pensionistiche e prolungamento dell'attività: analisi del TIR e effetti del cumulo lavoro-pensione," Working Papers CERM 07-2004, Competitività, Regole, Mercati (CERM).
  74. Claudia Oglialoro & Fabio Pammolli & Nicola Carmine Salerno, 2004. "Strumenti di regolazione del mercato farmaceutico: un'analisi ragionata," Working Papers CERM 03-2004, Competitività, Regole, Mercati (CERM).
  75. De Fabritiis, Gianni & Riccaboni, Massimo & Pammolli, Fabio, 2003. "On Size and Growth of Business Firms," MPRA Paper 15866, University Library of Munich, Germany.
  76. Gianluca Baio & Laura Magazzini & Antonio Nicita & Fabio Pammolli & Massimo Riccaboni, 2003. "Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato," Working Papers CERM 0-2003, Competitività, Regole, Mercati (CERM).
  77. Riccaboni, Massimo & Pammolli, Fabio, 2001. "On Firm Growth in Networks," MPRA Paper 15964, University Library of Munich, Germany, revised 12 Nov 2001.
  78. Giulio Bottazzi & Giovanni Dosi & Marco Lippi & Fabio Pammolli & Massimo Riccaboni, 2001. "Innovation and Corporate Growth in the Evolution of the Drug Industry," LEM Papers Series 2001/02, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  79. Fabio Pammolli & Massimo Riccaboni, 2001. "Technological Regimes and the Growth of Networks An Empirical Analysis," LEM Papers Series 2001/07, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  80. Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2001. "A Comparison of U.S. And European University-Industry Relations in the Life Sciences," LEM Papers Series 2001/03, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  81. Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio, 2000. "Global Competitiveness in Pharmaceuticals: A European Perspective," MPRA Paper 15965, University Library of Munich, Germany.
  82. Arora, Ashish & Gambardella, Alfonso & Pammolli, Fabio & Riccaboni, Massimo, 2000. "The Nature and the Extent of the Market for Technology in Biopharmaceuticals," MPRA Paper 15977, University Library of Munich, Germany.
  83. Giulio Bottazzi & Giovanni Dosi & Marco Lippi & Fabio Pammolli & Massimo Riccaboni, 2000. "Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals," LEM Papers Series 2000/05, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  84. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni, 1999. "Co-evolution of Organizational Forms and Technology," LEM Papers Series 1999/16, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  85. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni, 1999. "Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry," LEM Papers Series 1999/13, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  86. Fabio Pammolli & Massimo Riccaboni, 1999. "Networks Dynamics in the Pharmaceutical Industry," LEM Papers Series 1999/18, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  87. Andrea Bonaccorsi & Thomas Lyon & Fabio Pammolli & Giuseppe Turchetti, 1999. "Auctions vs. Bargaining: An Empirical Analysis of Medical Device Procurement," LEM Papers Series 1999/20, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  1. Michele Bonollo & Irene Crimaldi & Andrea Flori & Laura Gianfagna & Fabio Pammolli, 2016. "Assessing financial distress dependencies in OTC markets: a new approach using trade repositories data," Financial Markets and Portfolio Management, Springer;Swiss Society for Financial Market Research, vol. 30(4), pages 397-426, November.
  2. Jing-Yuan Chiou & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2016. "Learning from successes and failures in pharmaceutical R&D," Journal of Evolutionary Economics, Springer, vol. 26(2), pages 271-290, May.
  3. Morescalchi, Andrea & Pammolli, Fabio & Penner, Orion & Petersen, Alexander M. & Riccaboni, Massimo, 2015. "The evolution of networks of innovators within and across borders: Evidence from patent data," Research Policy, Elsevier, vol. 44(3), pages 651-668.
  4. Pammolli Fabio, 2014. "On Innovation, Instability, and Growth. A Review and an Interpretative Framework," Economia politica, Società editrice il Mulino, issue 1, pages 17-32.
  5. Pammolli Fabio & Baio Gianluca & Rungi Armando, 2014. "The price of pharmaceutical products in Italy. On some recent trends," Mercato Concorrenza Regole, Società editrice il Mulino, issue 2, pages 265-282.
  6. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2012. "The sustainability of European health care systems: beyond income and aging," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 623-634, October.
  7. Fabio Pammolli & Nicola C. Salerno, 2011. "La distribuzione dei farmaci tra progetti di riforma e incertezze," ECONOMIA E POLITICA INDUSTRIALE, FrancoAngeli Editore, vol. 2011(2), pages 125-148.
  8. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent disclosure and R&D competition in pharmaceuticals," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 467-486.
  9. Ashish Arora & Alfonso Gambardella & Laura Magazzini & Fabio Pammolli, 2009. "A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development," Management Science, INFORMS, vol. 55(10), pages 1638-1653, October.
  10. Growiec, Jakub & Pammolli, Fabio & Riccaboni, Massimo & Stanley, H. Eugene, 2008. "On the size distribution of business firms," Economics Letters, Elsevier, vol. 98(2), pages 207-212, February.
  11. S. V. Buldyrev & F. Pammolli & M. Riccaboni & K. Yamasaki & D.-F. Fu & K. Matia & H. E. Stanley, 2007. "A generalized preferential attachment model for business firms growth rates," The European Physical Journal B: Condensed Matter and Complex Systems, Springer;EDP Sciences, vol. 57(2), pages 131-138, 05.
  12. Sergey V. Buldyrev & Jakub Growiec & Fabio Pammolli & Massimo Riccaboni & H. Eugene Stanley, 2007. "The Growth of Business Firms: Facts and Theory," Journal of the European Economic Association, MIT Press, vol. 5(2-3), pages 574-584, 04-05.
  13. Maria Alessandra Rossi & Fabio Pammolli, 2005. "Intellectual property, technological regimes and market dynamics," ECONOMIA E POLITICA INDUSTRIALE, FrancoAngeli Editore, vol. 2005(2).
  14. Merito, Monica & Bonaccorsi, Andrea & Pammolli, Fabio & Riccaboni, Massimo & Baio, Gianluca & Arici, Claudio & Monforte, Antonella D'Arminio & Pezzotti, Patrizio & Corsini, Dario & Tramarin, Andrea & , 2005. "Economic evaluation of HIV treatments: The I.CO.N.A. cohort study," Health Policy, Elsevier, vol. 74(3), pages 304-313, November.
  15. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2004. "Dynamic competition in pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(2), pages 175-182, May.
  16. De Fabritiis, G. & Pammolli, F. & Riccaboni, M., 2003. "On size and growth of business firms," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 324(1), pages 38-44.
  17. Fabio Pammolli & Laura Magazzini & Luigi Orsenigo, 2002. "The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis," Revue d'Économie Industrielle, Programme National Persée, vol. 99(1), pages 107-131.
  18. Pammolli, Fabio & Riccaboni, Massimo, 2002. "Technological Regimes and the Growth of Networks: An Empirical Analysis," Small Business Economics, Springer, vol. 19(3), pages 205-215, November.
  19. Jason Owen-Smith & Massimo Riccaboni & Fabio Pammolli & Walter W. Powell, 2002. "A Comparison of U.S. and European University-Industry Relations in the Life Sciences," Management Science, INFORMS, vol. 48(1), pages 24-43, January.
  20. Riccaboni, Massimo & Pammolli, Fabio, 2002. "On firm growth in networks," Research Policy, Elsevier, vol. 31(8-9), pages 1405-1416, December.
  21. Orsenigo, L. & Pammolli, F. & Riccaboni, Massimo, 2001. "Technological change and network dynamics: Lessons from the pharmaceutical industry," Research Policy, Elsevier, vol. 30(3), pages 485-508, March.
  22. Bottazzi, Giulio & Dosi, Giovanni & Lippi, Marco & Pammolli, Fabio & Riccaboni, Massimo, 2001. "Innovation and corporate growth in the evolution of the drug industry," International Journal of Industrial Organization, Elsevier, vol. 19(7), pages 1161-1187, July.
  23. Luigi Orsenigo & Fabio Pammolli & Massimo Riccaboni & Andrea Bonaccorsi & Giuseppe Turchetti, 1997. "The Evolution of Knowledge and the Dynamics of an Industry Network," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 1(2), pages 147-175, June.
  24. Bonaccorsi, Andrea & Pammolli, Fabio & Tani, Simone, 1996. "The changing boundaries of system companies," International Business Review, Elsevier, vol. 5(6), pages 539-560, December.
  1. Massimo Riccaboni & Jason Owen-Smith & Walter W. Powell & Fabio Pammolli, 2003. "Public Research and Industrial Innovation: A Comparison of US and European Innovation Systems in the Life Sciences," Chapters,in: Science and Innovation, chapter 6 Edward Elgar Publishing.
  2. Fabio Pammolli & Massimo Riccaboni, 2003. "Technological Paradigms and the Evolution of Networks: Lessons from the Pharmaceutical Industry," Chapters,in: Applied Evolutionary Economics, chapter 2 Edward Elgar Publishing.
NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 33 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-INO: Innovation (9) 2009-06-10 2009-08-02 2009-08-02 2010-08-06 2011-04-16 2011-10-15 2013-07-15 2013-08-10 2014-01-24. Author is listed
  2. NEP-ENT: Entrepreneurship (8) 2002-05-03 2002-05-03 2002-05-03 2009-06-10 2009-08-02 2009-09-26 2011-04-16 2011-10-15. Author is listed
  3. NEP-TID: Technology & Industrial Dynamics (7) 2009-06-10 2009-08-02 2010-08-06 2011-04-16 2011-10-15 2013-07-15 2014-01-24. Author is listed
  4. NEP-CSE: Economics of Strategic Management (6) 2009-06-10 2009-08-02 2011-04-16 2011-10-15 2013-07-15 2014-01-24. Author is listed
  5. NEP-IPR: Intellectual Property Rights (6) 2009-06-10 2009-08-02 2011-04-16 2013-07-15 2013-08-10 2014-01-24. Author is listed
  6. NEP-NET: Network Economics (5) 2009-01-24 2013-08-10 2014-01-24 2014-09-25 2016-05-14. Author is listed
  7. NEP-RMG: Risk Management (5) 2014-04-18 2014-09-25 2015-01-26 2015-11-01 2017-01-22. Author is listed
  8. NEP-AGE: Economics of Ageing (4) 2012-03-08 2013-11-02 2017-01-15 2017-01-22
  9. NEP-COM: Industrial Competition (4) 2009-06-10 2009-08-02 2009-08-02 2013-07-15
  10. NEP-EUR: Microeconomic European Issues (4) 2013-08-10 2014-01-24 2016-01-29 2017-01-15
  11. NEP-HEA: Health Economics (4) 2002-05-03 2002-05-03 2012-03-08 2016-01-29
  12. NEP-SBM: Small Business Management (4) 2009-08-02 2011-04-16 2011-10-15 2013-08-10
  13. NEP-BAN: Banking (3) 2014-09-25 2015-01-26 2017-01-01
  14. NEP-PPM: Project, Program & Portfolio Management (3) 2009-06-10 2009-08-02 2013-07-15
  15. NEP-BEC: Business Economics (2) 2011-04-16 2011-10-15
  16. NEP-EFF: Efficiency & Productivity (2) 2010-08-06 2012-03-08
  17. NEP-GEO: Economic Geography (2) 2013-08-10 2014-01-24
  18. NEP-IND: Industrial Organization (2) 2009-08-02 2013-07-15
  19. NEP-KNM: Knowledge Management & Knowledge Economy (2) 2013-08-10 2014-01-24
  20. NEP-MIG: Economics of Human Migration (2) 2013-08-10 2017-01-15
  21. NEP-URE: Urban & Real Estate Economics (2) 2013-08-10 2014-01-24
  22. NEP-CBA: Central Banking (1) 2015-01-26
  23. NEP-CWA: Central & Western Asia (1) 2013-08-10
  24. NEP-FMK: Financial Markets (1) 2015-01-26
  25. NEP-GER: German Papers (1) 2015-08-30
  26. NEP-HME: Heterodox Microeconomics (1) 2016-05-14
  27. NEP-IAS: Insurance Economics (1) 2012-03-08
  28. NEP-INT: International Trade (1) 2017-01-15
  29. NEP-MAC: Macroeconomics (1) 2017-01-15
  30. NEP-MIC: Microeconomics (1) 2009-06-10
  31. NEP-MST: Market Microstructure (1) 2015-11-01
  32. NEP-REG: Regulation (1) 2014-09-25
This author is among the top 5% authors according to these criteria:
  1. Number of Works
  2. Number of Distinct Works
  3. Number of Abstract Views in RePEc Services over the past 12 months
  4. Number of Downloads through RePEc Services over the past 12 months
  5. Betweenness measure in co-authorship network

Most cited item

Most downloaded item (past 12 months)

Access and download statistics for all items

Co-authorship network on CollEc

For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Fabio Pammolli should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.